MAZZO DAVID J (Chief Executive Officer) received a stock award from LISATA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/2/2022ACC: 0001334549-22-000007
DirectorOfficer· Chief Executive Officer
Since Jan 2019
+80.26K
Net shares
Net buyer
$34.9K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
150K acquired · 69.74K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+150K
Price / share
$0.50
Trade value
$75K
% of position
22.8%
9/1/2022
659.19K→809.19K
Common Stock
Direct
Shares
−69.74K
Price / share
$0.50
Trade value
$34.87K
% of position
8.6%
9/1/2022
809.19K→739.44K
Total
Net shares
+80.26K
Net value
$40.13K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2022 | A · Award | +150K | $0.50 | $75K | 22.8% | 659.19K | 809.19K |
| Common Stock Direct | 9/1/2022 | F · Tax Withholding | −69.74K | $0.50 | $34.87K | 8.6% | 809.19K | 739.44K |
| Total | +80.26K | $40.13K | ||||||
Derivative Transactions0
No derivative transactions reported